Showing results (141-150 of 187) with videos related to
Sort By:
Pageof 19
Lancet (London, England)|July 20, 1991
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complexG Pialoux, M Youle, B Dupont, et al.Lancet (London, England)|September 1, 1984
Clinical findings and serological evidence of HTLV-III infection in homosexual contacts of patients with AIDS and persistent generalised lymphadenopathy in LondonB G Gazzard, D C Shanson, C Farthing, et al.Clinical and Experimental Immunology|August 4, 2007
Tuberculosis antigen-specific immune responses can be detected using enzyme-linked immunospot technology in human immunodeficiency virus (HIV)-1 patients with advanced diseaseS A Clark, S L Martin, A Pozniak, et al.Journal of Neurovirology|December 28, 2017
CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.Proceedings of the National Academy of Sciences of the United States of America|October 1, 1990
Polymerase chain reaction evidence for human immunodeficiency virus 1 neutralization by passive immunization in patients with AIDS and AIDS-related complexA Karpas, I K Hewlett, F Hill, et al.Journal of Neurovirology|January 11, 2018
Correction to: CSF inflammatory markers and neurocognitive function after addition of maraviroc to monotherapy darunavir/ritonavir in stable HIV patients: the CINAMMON studyT J Barber, A Imaz, M Boffito, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 1, 1995
HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID miceP S Sarin, C A Mora, P H Naylor, et al.Gut|December 1, 1985
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centresM I Filipe, F Potet, W V Bogomoletz, et al.AIDS Research and Human Retroviruses|January 16, 1998
A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: clinical tolerance and effect on activation markers and cytokinesJ B Marriott, S Cookson, E Carlin, et al.AIDS Research and Human Retroviruses|January 1, 1994
Characterization of HIV-1 strains isolated from patients treated with TIBO R82913A M Vandamme, Z Debyser, R Pauwels, et al.Pageof 19